Nickel 28 Releases Ramu 2023 Production and Provides 2024 Production Guidance

Nickel 28 Releases Ramu 2023 Production and Provides 2024 Production Guidance

TORONTO–(BUSINESS WIRE)–Nickel 28 Capital Corp. (“Nickel 28” or the “Company”) (TSXV: NKL) (FSE: 3JC0) is pleased to provide nickel and cobalt production levels for the Company’s largest asset, being the Ramu Nickel-Cobalt (“Ramu”) integrated operation in Papua New Guinea. Nickel 28 currently holds an 8.56% joint-venture interest in Ramu which is operated by Metallurgical Corporation … Read more

Lithium Royalty Corp. Provides 2023 Recap

Lithium Royalty Corp. Provides 2023 Recap

(in thousands of U.S. dollars unless otherwise noted) TORONTO–(BUSINESS WIRE)–$LIRC #LIRC–Lithium Royalty Corp. (TSX: LIRC) (“LRC” or the “Company”) is pleased to report on the successful conclusion of its inaugural year as a public company, following its initial public offering in March 2023, with an update on key developments in 2023 through into 2024. The … Read more

Australia & New Zealand Fleet Management Report 2024 – Installed Base of Fleet Management Systems in Australia and New Zealand to Exceed 2.4 Million Units by 2027

Australia & New Zealand Fleet Management Report 2024 – Installed Base of Fleet Management Systems in Australia and New Zealand to Exceed 2.4 Million Units by 2027

DUBLIN–(BUSINESS WIRE)–The “Fleet Management in Australia & New Zealand – 8th Edition” report has been added to ResearchAndMarkets.com’s offering. The report analyses the latest developments on the commercial vehicle telematics market in Australia and New Zealand. The report forecasts that the number of fleet management systems in active use in Australia and New Zealand will … Read more

Rare Element Resources Announces Plans for Management Change

Rare Element Resources Announces Plans for Management Change

LITTLETON, Colo.–(BUSINESS WIRE)–Rare Element Resources Ltd. (the “Company” or “RER”) (OTCQB: REEMF) announces that its President and Chief Executive Officer Brent Berg, has notified the Company that he will resign his position effective April 2, 2024, or earlier at the discretion of the RER Board of Directors (the “Board”). Mr. Berg, who has held that … Read more

Australia Remittance Market Sees Remarkable Growth: 2023 In-depth Analysis Revealed – Market to Attain a Transaction Value of $2.25 Billion by 2028

Australia Remittance Market Sees Remarkable Growth: 2023 In-depth Analysis Revealed – Market to Attain a Transaction Value of .25 Billion by 2028

DUBLIN–(BUSINESS WIRE)–The “Australia International Remittance Market Business and Investment Opportunities – Analysis by Transaction Value & Volume, Inbound and Outbound Transfers to and from Key States, Consumer Demographics – Q2 2023” report has been added to ResearchAndMarkets.com’s offering. The international remittance market in Australia, encompassing both inbound and outbound money transfers, has experienced notable expansion, … Read more

AdvanCell Appoints Anna Karmann, MD, PhD as Chief Medical Officer

AdvanCell Appoints Anna Karmann, MD, PhD as Chief Medical Officer

SYDNEY–(BUSINESS WIRE)–#CMO–AdvanCell, a clinical-stage radiopharmaceutical company developing a pipeline of Targeted Alpha Therapies for patients with cancer, today announced the appointment of Anna Karmann, MD, PhD as the company’s Chief Medical Officer based in San Francisco. Dr. Karmann joins from RayzeBio, recently acquired by Bristol Myers Squibb, where she led the development of early-stage assets … Read more

Longboard Pharmaceuticals to Host Call to Discuss Topline Data from the PACIFIC Study, a Phase 1b/2a Clinical Trial for Bexicaserin (LP352) in Participants with Developmental and Epileptic Encephalopathies (DEEs)

Longboard Pharmaceuticals to Host Call to Discuss Topline Data from the PACIFIC Study, a Phase 1b/2a Clinical Trial for Bexicaserin (LP352) in Participants with Developmental and Epileptic Encephalopathies (DEEs)

• Conference call and webcast to be held tomorrow, January 2, at 8:30am ET (5:30am PT) LA JOLLA, Calif.–(BUSINESS WIRE)–$LBPH #Epilepsy—Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced that it will host a conference call to discuss topline data from the PACIFIC Study, … Read more

Graybar chooses DataXstream OMS+ for Sales, Order Management and Point of Sale

Graybar chooses DataXstream OMS+ for Sales, Order Management and Point of Sale

OMS+ multi-channel platform will extend Graybar’s SAP ERP, support upgrades to SAP S/4, and offer streamlined sales and order processing with omnichannel capabilities. WILLIAMSBURG, Va.–(BUSINESS WIRE)–DataXstream LLC, an SAP solution provider focused on order management for sales and distribution, today announced that Graybar, a leading North American distributor of high quality electrical, industrial, communications and … Read more

BiVACOR Names Veteran Medical Device Executive Jim Dillon as Chief Executive Officer

BiVACOR Names Veteran Medical Device Executive Jim Dillon as Chief Executive Officer

HUNTINGTON BEACH, Calif. & HOUSTON & GOLD COAST, Australia–(BUSINESS WIRE)–BiVACOR, Inc., a clinical-stage medical technology company developing a total artificial heart (TAH), today announced that Jim Dillon has been named chief executive officer and a member of its board of directors. Mr. Dillon is an experienced medical device executive whose career focus in heart failure … Read more

Top Founders to Follow in 2024

Top Founders to Follow in 2024

* This is a contributed article and this content does not necessarily represent the views of IBTimes. As 2024 unfolds, the Australian business landscape is at a pivotal juncture, shaped by global economic challenges and local market transformations. In a time when the Australian economy grapples with uncertainties, from fluctuating international trade dynamics to local … Read more